Equities

Acadia Healthcare Company Inc

Acadia Healthcare Company Inc

Actions
  • Price (USD)30.12
  • Today's Change1.28 / 4.44%
  • Shares traded625.30k
  • 1 Year change-9.55%
  • Beta1.3843
Data delayed at least 15 minutes, as of Jun 05 2020 21:00 BST.
More ▼

Profile data is unavailable for this security.

About the company

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities. The Company is engaged in operating acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers and facilities providing outpatient behavioral healthcare services. Its U.S. Facilities include approximately 224 behavioral healthcare facilities with approximately 9,500 beds in 40 states and Puerto Rico. The Company’s U.K. Facilities include approximately 361 behavioral healthcare facilities with approximately 8,700 beds in the United Kingdom. The Company operates a network of approximately 588 behavioral healthcare facilities with approximately 18,200 beds in 40 states, the United Kingdom and Puerto Rico.

  • Revenue in USD (TTM)3.13bn
  • Net income in USD112.92m
  • Incorporated2005
  • Employees28.40k
  • Location
    Acadia Healthcare Company Inc6100 Tower Cir Ste 1000FRANKLIN 37067-1509United StatesUSA
  • Phone+1 (615) 861-6000
  • Fax+1 (615) 261-9685
  • Websitehttp://www.acadiahealthcare.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CareDx Inc139.47m-20.26m1.40bn306.00--13.53--10.01-0.4775-0.47753.292.360.97997.947.89455,771.30-14.24-23.24-16.89-33.2965.5059.09-14.53-32.822.09--0.00--65.9536.0153.02--35.51--
MEDNAX Inc3.51bn-1.21bn1.45bn5.17k--0.9738--0.4141-14.65-15.4542.4117.470.6998--7.02679,240.40-24.090.2904-26.080.3204-----34.430.4587--3.530.5857--1.707.57-544.72--12.04--
Addus Homecare Corporation598.55m20.50m1.53bn4.88k65.523.2751.462.561.511.4743.9830.211.14--4.89122,780.103.905.884.507.5027.0626.853.423.32--13.280.1136--21.6314.2728.409.2543.24--
BioTelemetry Inc448.16m25.27m1.67bn1.70k70.244.4223.523.720.69450.694512.3111.040.6420.307.52263,622.903.616.713.927.5362.4861.715.648.174.196.470.37690.009.9221.39-30.30--19.16--
Magellan Health Inc7.21bn73.72m1.82bn10.10k24.701.278.980.25282.962.96288.8757.342.29155.438.37714,281.302.342.203.413.313.603.811.020.96431.717.340.33830.00-2.1213.75128.02-6.78-0.6287--
Progyny Inc263.51m-4.54m2.10bn167.00--17.25--7.96-0.0639-0.06393.041.432.22--4.941,577,904.00-5.92---10.40--19.79---2.67------0.00--117.92--24.29------
Tenet Healthcare Corp18.45bn-122.00m2.22bn88.61k----2.040.1205-1.18-1.16176.61-3.420.78569.746.38208,265.601.050.68711.420.955383.3283.831.330.83741.242.060.8826--0.90652.16-325.00---6.41--
Select Medical Holdings Corporation5.54bn155.27m2.29bn35.70k14.302.835.330.41371.201.2042.686.040.7843--6.95155,292.003.093.094.094.1015.0614.293.933.45--2.830.69122.137.3312.227.634.1110.53--
The Ensign Group, Inc.2.08bn105.17m2.37bn24.50k23.493.5014.981.141.882.2237.0912.580.9018--6.6984,772.374.595.155.366.5120.9416.805.093.35--11.420.339116.2216.0714.6654.1220.5928.176.30
Acadia Healthcare Company Inc3.13bn112.92m2.57bn28.40k22.451.039.170.81961.281.2835.6328.050.4635--9.32110,199.101.700.83481.840.8946----3.661.690.85942.210.56090.003.1525.34161.845.5316.46--
Option Care Health Inc2.54bn-92.12m2.65bn5.08k--3.05--1.04-0.5503-0.550315.134.931.5823.6111.09499,776.60-5.74-11.52-6.79-14.1222.5626.89-3.63-8.071.220.03290.5963--225.9120.15-20.89--15.39--
Agape ATP Corp825.84k-1.02m2.82bn----700.73--3,417.21-0.0027-0.00270.00220.01070.1787--2.33---22.06---22.52--5.47---123.40-----10.060.00--------------
NeoGenomics, Inc.419.28m3.45m3.04bn1.70k864.325.7487.777.250.03180.03183.984.790.662614.904.59246,637.100.5455-0.07380.6136-0.08346.7745.160.8233-0.11352.883.160.1694--47.7336.2531.5047.8839.64--
Irhythm Technologies Inc229.75m-55.38m3.34bn997.00--26.70--14.53-2.13-2.138.864.621.1516.878.76230,444.30-27.68-30.28-33.70-36.6175.2972.37-24.11-31.793.51-34.530.2185--45.6858.06-8.32--106.94--
Data as of Jun 05 2020. Currency figures normalised to Acadia Healthcare Company Inc's reporting currency: US Dollar USD

Institutional shareholders

69.77%Per cent of shares held by top holders
HolderShares% Held
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 202013.08m14.73%
Wellington Management Co. LLPas of 31 Mar 202011.56m13.02%
The Vanguard Group, Inc.as of 31 Mar 20208.34m9.40%
BlackRock Fund Advisorsas of 31 Mar 20207.25m8.17%
Dimensional Fund Advisors LPas of 31 Mar 20206.20m6.98%
P2 Capital Partners LLCas of 31 Mar 20205.58m6.28%
JPMorgan Investment Management, Inc.as of 31 Mar 20203.63m4.09%
Abrams Bison Investments LLCas of 31 Mar 20202.30m2.59%
SSgA Funds Management, Inc.as of 31 Mar 20202.26m2.55%
Davide Leone & Partners Investment Co. Ltd.as of 31 Mar 20201.75m1.97%
More ▼
Data from 31 Mar 2020 - 31 Mar 2020Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.